Treatment of basal cell carcinoma with curettage alone

James O. Barlow, Mark J. Zalla, Amber Kyle, David J. DiCaudo, Katherine K. Lim, James A. Yiannias

Research output: Contribution to journalArticlepeer-review

52 Scopus citations


Background: Although curettage and electrodesiccation (C&E) is widely used to treat basal cell carcinoma, whether electrodesiccation improves outcome is unknown. Objective: We sought to compare cure rates of curettage alone with those of C&E. Methods: We conducted a retrospective records review of patients treated with curettage alone at 5-year follow-up or longer that extracted data about tumor location, size, histologic subtype, biopsy specimen margin involvement, and recurrence, as well as data about the medical history of patients treated in a dermatology clinic in a tertiary-care academic medical institution. Results: Biopsy-proven tumors (302) amenable to treatment with C&E and treated by a single investigator with curettage alone had a 5-year cure rate of 96.03%, with minimal complications (hypopigmentation, scarring). Tumors involving more than 50% of the deep edge of the shave biopsy specimen had an increased risk of recurrence. Limitations: This is a retrospective study based on historic controls. Conclusion: For nonaggressive basal cell carcinoma, curettage alone has a cure rate similar to the published rates for C&E.

Original languageEnglish (US)
Pages (from-to)1039-1045
Number of pages7
JournalJournal of the American Academy of Dermatology
Issue number6
StatePublished - Jun 1 2006

ASJC Scopus subject areas

  • Dermatology


Dive into the research topics of 'Treatment of basal cell carcinoma with curettage alone'. Together they form a unique fingerprint.

Cite this